-+ 0.00%
-+ 0.00%
-+ 0.00%

Profusa Collaborates With MedSell To Commercialize Lumee Oxygen Tissue Monitoring In France

Benzinga·12/31/2025 12:31:32
Listen to the news

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces a new distributor partnership in France with MedSell.  MedSell is a French company that specializes in the commercialization and distribution of innovative medical devices within the French healthcare market by leveraging tailored commercial, marketing, and market-entry support services.  As part of its portfolio, Profusa's new partner will commercialize Lumee Oxygen tissue monitoring in France in both hospital settings and outpatient care, especially in wound care and healing clinics addressing patients with complex and chronic wounds.